ClinicalTrials.gg
RecruitingNCT07404956Updated Feb 12, 2026

THE EFFECT OF SURGICAL MASK AND N95 MASK USE ON SURGICAL SMOKE IN OPERATING ROOM NURSES

An interventional study of Surgical Mask and N95 Mask in Surgical Smoke Exposure, Occupational Exposure to Surgical Smoke and Headache, sponsored by Bartın Unıversity. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-12.

Sponsored by Bartın Unıversity · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Sep 2024, registered Dec 2025).
  • Started Sep 2024; still recruiting 2 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study was conducted to compare the effect of surgical mask and N95 mask use on physical symptoms due to surgical smoke in operating theatre nurses. The study, which was conducted in a single-group prospective quasi-experimental design, was completed with 38 nurses in the operating theatre unit of a state hospital in the Western Black Sea Region. Data were collected for four weeks using the Descriptive Information Form, Numerical Rating Scale and Symptom Follow-up Form. According to the findings, muscle weakness, myalgia in the upper extremities and muscle cramps were statistically significantly less in nurses using N95 masks. Respiratory parameters, watery eyes and redness were significantly lower in nurses using surgical masks. As a result, it was determined that the type of mask was effective on the incidence of physical symptoms related to surgical smoke.

02

Conditions studied

  • Surgical Smoke Exposure
  • Occupational Exposure to Surgical Smoke
  • Headache
  • Dizziness
  • Nause and Vomiting
  • Fatigue Symptom
  • Eye Allergies
  • Abdominal Pain (AP)
  • Heart Rate Determination
  • SpO2
  • Muscle Weakness | Patient
  • Muscle Aches
  • Dispnea

Keywords

  • Surgical Smoke
  • Masks
  • Operating Room Nurses
  • Occupational Exposure
03

In context

Headache

762 studies on the registry are indexed under Headache; 134 are open to participants now.

This study's planned enrollment of 38 is below the median of 65 across 560 interventional studies indexed under Headache.

Browse Headache studies →

Lead sponsor

Bartın Unıversity is the lead sponsor of 47 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Willingness to participate in the study
  • Aged 18 years or older
  • Working as a sterile operating room nurse at least 4 hours per day, 5 days per week
  • Compliance with the protocol requiring continuous use of both surgical mask and N95 mask for at least 4 hours per day
  • Ability to communicate verbally and provide

Exclusion criteria

Exclusion Criteria:

  • Diagnosed psychiatric disorders
  • Presence of chronic respiratory, musculoskeletal, or neurological diseases
  • Presence of chronic dermatological conditions or allergies affecting the facial or respiratory area
  • Speech or communication impairments
  • Pregnancy
  • Holding a supervisory role (e.g., charge nurse) or non-sterile nursing role
  • Planned unit change or rotation during the study period
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
38 participants (estimated)

Study arms

  • Experimental
    Surgical Mask

    Operating room nurses used a standard surgical mask during surgical procedures with exposure to surgical smoke.

    Device: Surgical Mask

  • Experimental
    N95 Mask

    Operating room nurses used an N95 respirator during surgical procedures with exposure to surgical smoke.

    Device: N95 Mask

Interventions

  • DeviceSurgical Mask

    Standard surgical masks were used by operating room nurses during surgical procedures with exposure to surgical smoke.

    Also known as: Medical Surgical Mask

  • DeviceN95 Mask

    N95 respirators were used by operating room nurses during surgical procedures with exposure to surgical smoke.

    Also known as: N95 Respirator

06

What researchers measure

Primary outcomes

  1. Surgical Smoke-Related Physical Symptom Severity (Total NRS Score)

    The severity of physical symptoms related to surgical smoke exposure in operating room nurses, including headache, abdominal pain, nausea and vomiting, fatigue/weakness, loss of appetite, and dyspnea, was assessed using the Numeric Rating Scale (NRS). Each symptom was rated on a standardized numeric scale, and a total symptom severity score was calculated by summing the individual symptom scores. Higher scores indicate greater symptom severity.

    Time frame: Five days per week for a duration of four weeks both preoperatively and postoperatively

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07404956
Lead sponsor
Bartın Unıversity
Collaborators
Bartin State Hospital
Responsible party
Hilal Çetin Baltutar (Nurse, Bartın Unıversity) — Principal investigator
First posted
Feb 12, 2026
Start date
Sep 15, 2024
Primary completion
Sep 15, 2025
Completion
Feb 28, 2026 (estimated)
Last update
Feb 12, 2026

Study contacts

Hilal Çetin Baltutar, Nurse
Contact
hilalcetinbaltutar@gmail.com
+905336087874
Sevim Çelik, Proffessor
Contact
scelik@bartin.edu.tr
+905327832989
sevim çelik, Professor
principal investigator · Bartin University Health Science Faculty

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion